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汎血球減少を呈した骨髄原発悪性リンパ腫の1例
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Bone marrow lymphoma is a rare disease. Herein, we report a case of a 77-year old woman who was diag-
nosed with primary bone marrow lymphoma. She presented with fatigue and dyspnea 1 month before hospitali-
zation. Two weeks before hospitalization, she underwent blood tests, and her complete blood count revealed pan-
cytopenia. A bone marrow biopsy was performed and showed abnormal and diffuse lymphoid cells. On immuno-
histochemistry, these cells were positive for leukocyto common antigen (LCA), CD20, and Bcl-2. Upon further ex-
amination, there was no palpable lymphadenopathy. A positron emission/computed tomography (PET/CT) scan
revealed fluorodeoxyglucose (FDG) uptake only by the vertebra and pelvic bone. The patient received R-T-COP
chemotherapy (rituximab, cyclophosphamide, pirarubicin, vincristine, and prednisolone). Despite chemotherapy,
the disease became refractory, and the patient died 3 months after chemotherapy. Based on this case, we recom-
mend for pancytopenia to be considered a symptom of bone marrow lymphoma.























入院時検査所見：白血球 1,410/μl（好中球 64.5 %，
リンパ球 25.5 %，単球 4.0 %，好酸球 5.5 %，好塩基
球 0.5 %），Hb 6.8 g/dl，血小板 3.5×104/μl，網赤血球
1.9×104/μlと汎血球減少を認めたが，末梢血中に異
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Fig.　1　Histological bone marrow findings
Large abnormal lymphocytes were observed with diffuse spread, under hematoxylin and 
eosin staining (A, B) and were positive for CD20 (C) and bcl-2 (D).
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Table　1　Laboratory findings at the time of diagnosis
<CBC> <Chemistry> <Bone marrow aspiration>
RBC 234×104 /µl T-P 5.7 g/dl NCC 0.3×104 /µl
Hb 6.8 g/dl Alb 3.5 g/dl MgK ＜15.6 /µl
Ht 20.4 % AST 23 U/L G/E 15.60
MCV 87.2 fl ALT 13 U/L 46,XX [20]
MCH 29.1 pg LDH 691 U/L <Bone marrow biopsy>
MCHC 33.3 g/dl γ-GTP 20 U/L LCA＋, CD20＋, Cd79a＋, Bcl-2＋
WBC 1.41×103 /µl T-Bil 1.7 mg/dl
Neu 64.5 % BUN 15.8 mg/dl
Eo 5.5 % Cre 0.49 mg/dl
Bas 0.5 % CRP 5.22 mg/dl
Lym 25.5 % BUN 15.8 mg/dl
















骨髄原発と考えられた（Fig. 2）．入院 20日目に R-
T-COP療法（rituximab，cyclophosphamide，piraru-
bicin，vincristine，prednisolone）を施行した．治療











Fig.　2　Positron emission tomography showing uptake in the bone marrow
Fig.　3　Clinical course and treatment









































またchronic lymphocytic leukemia/small lympho-
cytic lymphona (CLL/SLL )，plasmablastic lym-
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